Research Blog
Evidence-based articles on peptide mechanisms, dosing protocols, clinical data, and research methodology. Cited sources. No hype.
The CJC-1295 + Ipamorelin Stack: Research Rationale and Synergy Data
CJC-1295 and Ipamorelin target different receptor systems — GHRH receptors and GHS-R1a respectively — creating synergistic GH pulses that exceed either compound alone. A mechanistic breakdown of why the combination works.
AOD 9604 Research: What 900 Clinical Trial Participants Taught Us About This GH Fragment
AOD 9604 went through multiple human clinical trials enrolling 900+ participants before Metabolic Pharmaceuticals discontinued it in 2007. The story of what those trials found — and why the compound failed commercially despite real efficacy signals — is one of the most instructive in peptide research.
Growth Hormone Secretagogues Explained: The Researcher's Guide to GHRH and GHRP Peptides
GHRH analogs like CJC-1295 and ghrelin mimetics like Ipamorelin work through distinct pathways to stimulate the body's own GH production — a fundamentally different approach from exogenous growth hormone. Here's the endocrinology behind how they work.